|
|
 |
 |
Search Results for: S |
 |
|
 |
|
|
 |
| 16 |
Solifenacin Succinate
Solifenacin is a urinary antispasmodic of the anticholinergic class. It is used in the treatment of overactive bladder with or without urge incontinence.
View Detail
| List of Intermediates
|
 |
|
|
| 17 |
Somatostatin
Somatostatin (also known as growth hormone-inhibiting hormone (GHIH) or somatotropin release-inhibiting factor (SRIF)) is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with ....
View Detail
| List of Intermediates
|
 |
|
|
| 18 |
Sorafenib tosylate
Sorafenib is a drug approved for the treatment of advanced renal cell carcinoma i.e. primary kidney cancer. Manus Aktteva offers Sorafenib tosylate, 475207-59-1, for RND and Sorafenib Intermediates for your evaluation, pilots and commercial requirem....
View Detail
| List of Intermediates
|
 |
|
|
| 19 |
Strontium Ranelate
Strontium ranelate, a strontium(II) salt of ranelic acid, is a medication for osteoporosis. It is unusual in the sense that it both increases deposition of new bone osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promot....
View Detail
| List of Intermediates
|
 |
|
|
| 20 |
Succinylcholine chloride
Manus Aktteva offers Succinylcholine chloride, 71-27-2,with Technical Package & DMF for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
| List of Intermediates
|
 |
|
|
| 21 |
Succinylcholine Chloride Sterile USP
Manus Aktteva offers Succinylcholine Chloride Sterile USP, 71-27-2,for your RND evaluation with supportive technical package required for evaluation. DMF also can be offered for this product
View Detail
| List of Intermediates
|
 |
|
|
| 22 |
Sunitinib Malate
Sunitinib is the cancer drug simultaneously approved for two different indications i.e. for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor. Manus Aktteva offers Sunitinib malate, 341031-54-7, for RND and S....
View Detail
| List of Intermediates
|
 |
|
|
| 23 |
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline
Manus Aktteva offers Solifenacin Succinate Intermediate,(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline, 118864-75-8, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 24 |
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride
Manus Aktteva offers Ivabradine intermediates, (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride, 866783-13-3, for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 25 |
(1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane
Manus Aktteva offers 110567-22-1,(1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane, and other Entecavir monohydrate Intermediates, for your evaluation,pilots and commercial requirements with supportive technical pack....
View Detail
|
 |
|
|
| 26 |
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
Manus Aktteva offers 142217-77-4,(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol, ,and other Entecavir Intermediates, for your evaluation,pilots and commercial requirements with supportive technica....
View Detail
|
 |
|
|
| 27 |
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester
Manus Aktteva offers Saxagliptin Intermediate,361440-67-7, (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester,for your evaluation,pilots and commercial requirements with supportive technical package required for....
View Detail
|
 |
|
|
| 28 |
(1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate
Manus Aktteva offers Oseltamivir phosphate Intermediate,204254-96-6, (1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate,for your evaluation,pilots and commercial requirements with supportive technical package required f....
View Detail
|
 |
|
|
| 29 |
(2S,4E)-5-chloro-2-(1-methylethyl)-4-Pentenoic acid
Manus Aktteva offers Aliskiren hemifumarate Intermediate, (2S,4E)-5-chloro-2-(1-methylethyl)-4-Pentenoic acid, 324519-66-6,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation....
View Detail
|
 |
|
|
| 30 |
(2S,4E,7R)-7-[[4-Methoxy-3-(3-methoxypropoxy) phenyl]methyl]-8-methyl-2-(1-methylethyl)-4-nonenoic acid methyl ester
Manus Aktteva offers Aliskiren hemifumarate Intermediate, (2S,4E,7R)-7-[[4-Methoxy-3-(3-methoxypropoxy) phenyl]methyl]-8-methyl-2-(1-methylethyl)-4-nonenoic acid methyl ester, 387353-71-1,for your requirements of RND, evaluation, pilots and commercia....
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|